UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Impact of novel hemophilia therapies around the world

Research and practice in thrombosis and haemostasis, 2022-03, Vol.6 (3), p.e12695-n/a, Article e12695

2022

Volltextzugriff (PDF)

Promoting pain coping skills in haemophilia: A remote intervention integrating exercise and pain education

Haemophilia : the official journal of the World Federation of Hemophilia, 2024-05, Vol.30 (3), p.800-808

2024

Volltextzugriff (PDF)

Chronic pain in patients with hemophilia: Influence of kinesiophobia and catastrophizing thoughts

Haemophilia : the official journal of the World Federation of Hemophilia, 2023-01, Vol.29 (1), p.386-389

2023

Volltextzugriff (PDF)

A retrospective analysis of 122 immune thrombocytopenia patients treated with dapsone: Efficacy, safety and factors associated with treatment response

Journal of thrombosis and haemostasis, 2021-09, Vol.19 (9), p.2275-2286

2021

Volltextzugriff (PDF)

Longitudinal sequencing of RUNX1 familial platelet disorder: new insights into genetic mechanisms of transformation to myeloid malignancies

British journal of haematology, 2019-09, Vol.186 (5), p.724-734

2019

Volltextzugriff (PDF)

Immunogenicity of Current and New Therapies for Hemophilia A

Pharmaceuticals (Basel, Switzerland), 2022-07, Vol.15 (8), p.911

2022

Volltextzugriff (PDF)

Corrigendum to “Low prevalence of Post-thrombotic syndrome in patients treated with rivaroxaban” [Vascular Pharmacology 124 (2020)/106608]

Vascular pharmacology, 2020-10, Vol.133-134, p.106780-106780, Article 106780

2020

Volltextzugriff (PDF)

Gene therapy for hemophilia: looking beyond factor expression

Experimental Biology and Medicine, 2022-12, Vol.247 (24), p.2223-2232

2022

Volltextzugriff (PDF)

Gene Therapy: Paving New Roads in the Treatment of Hemophilia

Seminars in thrombosis and hemostasis, 2019-10, Vol.45 (7), p.743-750

2019

Volltextzugriff (PDF)

Low prevalence of Post-thrombotic syndrome in patients treated with rivaroxaban

Vascular pharmacology, 2020-01, Vol.124, p.106608-106608, Article 106608

2020

Volltextzugriff (PDF)

Plain language summary of the GENEr8-1 clinical trial of valoctocogene roxaparvovec gene therapy for hemophilia A

Future Rare Diseases, 2023-12, Vol.3 (4)

2023

Volltextzugriff (PDF)

Incidence of Inhibitors in Previously Untreated Patients with Severe Hemophilia a Treated with Plasma-Derived Vs. Recombinant Factor VIII Concentrates: A Systematic Review and Meta-Analyses

Blood, 2022-11, Vol.140 (Supplement 1), p.57-58

2022

Volltextzugriff (PDF)

Acquired Hemophilia a Relapse Is Related to Th2 Response, and Increased Expression of B-Cell Activating Factor (BAFF)

Blood, 2021-11, Vol.138 (Supplement 1), p.497-497

2021

Volltextzugriff (PDF)

Global Fibrinolysis Analysed By Clofal Method Is Not Associated with Post-Thrombotic Syndrome or Presence of Residual Vein Thrombosis in Patients with DVT in the Chronic Phase

Blood, 2019-11, Vol.134 (Supplement_1), p.2403-2403

2019

Volltextzugriff (PDF)

Association of Plasmic Score with Neurological Symptoms in Patients with Thrombotic Thrombocytopenic Purpura (TTP)

Blood, 2019-11, Vol.134 (Supplement_1), p.4894-4894

2019

Volltextzugriff (PDF)

A Retrospective Analysis of 122 Immune Thrombocytopenia Patients Treated with Dapsone: Efficacy, Safety and Factors Associated with Treatment Response

Blood, 2018-11, Vol.132 (Supplement 1), p.737-737

2018

Volltextzugriff (PDF)

Longitudinal sequencing of RUNX 1 familial platelet disorder: new insights into genetic mechanisms of transformation to myeloid malignancies

British journal of haematology, 2019-09, Vol.186 (5), p.724-734

2019

Volltextzugriff (PDF)

Somatic Mutations Associated with Myeloid Transformation of RUNX1 -Mutated Familial Platelet Disorders with Propensity to Myeloid Malignancies Using Targeted Next-Generation Sequencing

Blood, 2017-12, Vol.130, p.2482-2482

2017

Volltextzugriff (PDF)

Clinical Course of Primary Immune Thrombocytopenia with Positive Antiphospholipid Antibodies

Blood, 2018-11, Vol.132 (Supplement 1), p.1159-1159

2018

Volltextzugriff (PDF)

A Simple Bundle to Control an Outbreak of Carbapenem-Resistant Enterobacteriacae in an Onco-Hematological Inpatient Unit: Report from a Single Center

Blood, 2017-12, Vol.130, p.4651-4651

2017

Volltextzugriff (PDF)

Incidence of Inhibitors in a Previously Untreated Patients with Severe Hemophilia Α Cohort Treated with a Single Third-Generation Recombinant Factor VIII Concentrate

Blood, 2018-11, Vol.132 (Supplement 1), p.1211-1211

2018

Volltextzugriff (PDF)

Vinorelbine-Based Hematopoietic Stem-Cell Mobilization: A More Effective, Low-Cost Alternative to Conventional Chemotherapy

Blood, 2018-11, Vol.132 (Supplement 1), p.4762-4762

2018

Volltextzugriff (PDF)

Evaluation of Predictors of Outcome in Immune Tolerance Induction Treatment of Hemophilia Α Patients with High-Responding Inhibitors

Blood, 2017-12, Vol.130, p.2357-2357

2017

Volltextzugriff (PDF)

Vinorelbine-Based Hematopoietic Stem-Cell Mobilization: A More Effective, Low-Cost Alternative to Conventional Chemotherapy

Biology of blood and marrow transplantation, 2019-03, Vol.25 (3), p.S222-S223

2019

Volltextzugriff (PDF)

1 – 24 von 24

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(23)

Publikationsform

Artikel
(24)

Sprache

Englisch
(24)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Impact of novel hemophilia therapies around the world

Promoting pain coping skills in haemophilia: A remote intervention integrating exercise and pain education

Chronic pain in patients with hemophilia: Influence of kinesiophobia and catastrophizing thoughts

A retrospective analysis of 122 immune thrombocytopenia patients treated with dapsone: Efficacy, safety and factors associated with treatment response

Longitudinal sequencing of RUNX1 familial platelet disorder: new insights into genetic mechanisms of transformation to myeloid malignancies

Immunogenicity of Current and New Therapies for Hemophilia A

Corrigendum to “Low prevalence of Post-thrombotic syndrome in patients treated with rivaroxaban” [Vascular Pharmacology 124 (2020)/106608]

Gene therapy for hemophilia: looking beyond factor expression

Gene Therapy: Paving New Roads in the Treatment of Hemophilia

Low prevalence of Post-thrombotic syndrome in patients treated with rivaroxaban

Plain language summary of the GENEr8-1 clinical trial of valoctocogene roxaparvovec gene therapy for hemophilia A

Incidence of Inhibitors in Previously Untreated Patients with Severe Hemophilia a Treated with Plasma-Derived Vs. Recombinant Factor VIII Concentrates: A Systematic Review and Meta-Analyses

Acquired Hemophilia a Relapse Is Related to Th2 Response, and Increased Expression of B-Cell Activating Factor (BAFF)

Global Fibrinolysis Analysed By Clofal Method Is Not Associated with Post-Thrombotic Syndrome or Presence of Residual Vein Thrombosis in Patients with DVT in the Chronic Phase

Association of Plasmic Score with Neurological Symptoms in Patients with Thrombotic Thrombocytopenic Purpura (TTP)

A Retrospective Analysis of 122 Immune Thrombocytopenia Patients Treated with Dapsone: Efficacy, Safety and Factors Associated with Treatment Response

Longitudinal sequencing of RUNX 1 familial platelet disorder: new insights into genetic mechanisms of transformation to myeloid malignancies

Somatic Mutations Associated with Myeloid Transformation of RUNX1 -Mutated Familial Platelet Disorders with Propensity to Myeloid Malignancies Using Targeted Next-Generation Sequencing

Clinical Course of Primary Immune Thrombocytopenia with Positive Antiphospholipid Antibodies

A Simple Bundle to Control an Outbreak of Carbapenem-Resistant Enterobacteriacae in an Onco-Hematological Inpatient Unit: Report from a Single Center

Incidence of Inhibitors in a Previously Untreated Patients with Severe Hemophilia Α Cohort Treated with a Single Third-Generation Recombinant Factor VIII Concentrate

Vinorelbine-Based Hematopoietic Stem-Cell Mobilization: A More Effective, Low-Cost Alternative to Conventional Chemotherapy

Evaluation of Predictors of Outcome in Immune Tolerance Induction Treatment of Hemophilia Α Patients with High-Responding Inhibitors

Vinorelbine-Based Hematopoietic Stem-Cell Mobilization: A More Effective, Low-Cost Alternative to Conventional Chemotherapy

Suchergebnisse filtern